FIELD: chemistry.
SUBSTANCE: invention relates to novel therapeutically suitable derivatives of pyridazin-3(2H)-one of formula and pharmaceutical compositions containing the said derivatives. These compounds are used for treating, preventing or inhibiting corresponding pathological conditions, diseases or disorders, mainly asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, atopic dermatitis, psoriasis or irritable colon syndrome.
EFFECT: obtaining compounds which are active and selective phosphodiesterase 4 (PDE4) inhibitors.
11 cl, 1 tbl, 182 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF PYRIDAZIN-3(2H)-ON AND THEIR APPLICATION AS INHIBITORS OF FDE4 | 2005 |
|
RU2376293C2 |
NEW DERIVATIVES OF PYRIDAZIN-3(2H)-ONE | 2003 |
|
RU2346939C2 |
PYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE | 2009 |
|
RU2473549C2 |
HETEROARYLALKYLCARBAMATE DERIVATIVES, THEIR OBTAINING AND THEIR APPLICATION AS ENZYME FAAH INHIBITORS | 2005 |
|
RU2364586C2 |
NOVEL PYRIDINONES AND PYRIDAZINONES | 2009 |
|
RU2505538C2 |
PYRIDINONE PYRIDAZINONE DERIVATIVES AS INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE (PARP) | 2007 |
|
RU2472782C2 |
MELANOCORTIN RECEPTOR MODULATORS, METHOD FOR PRODUCTION THEREOF AND USE THEREOF IN MEDICINAL AND COSMETIC PREPARATIONS FOR HUMAN USE | 2009 |
|
RU2589056C2 |
BRUTON'S TYROSINE KINASE INHIBITORS | 2010 |
|
RU2542585C2 |
ANTAGONISTS OF PEPTIDE RECEPTOR FIXED WITH CALCITONIN GENE | 2003 |
|
RU2341526C2 |
PYRIDONE AND AZA-PYRIDONE COMPOUNDS AND METHODS OF USE | 2011 |
|
RU2617405C2 |
Authors
Dates
2010-04-20—Published
2005-06-21—Filed